metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Información de la revista
Número
Vol. 29. Núm. 5.
(septiembre - octubre 2024)
Editorial board
Ann Hepatol. 2024;29:101560
Acceso a texto completo
Editorial
Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury
Nelia Hernandez, Fernando Bessone, Raul Andrade
Ann Hepatol. 2024;29:101520
Acceso a texto completo
Concise reviews
Frailty and sarcopenia in patients with acute-on-chronic liver failure: Assessment and risk in the liver transplant setting
Isabel Campos-Varela, Lluis Castells, Sergi Quiroga, Victor Vargas, Macarena Simon-Talero
Ann Hepatol. 2024;29:101515
Acceso a texto completo
Original articles
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease
Ziyan Pan, Moutaz Derbala, Khalid AlNaamani, Hasmik Ghazinian, Jian-Gao Fan, Mohammed Eslam
Ann Hepatol. 2024;29:101512
Acceso a texto completo
Palliative care and end stage liver disease: A cohort analysis of palliative care use and factors associated with referral
Hugo M Oliveira, Helena Pessegueiro Miranda, Francisca Rego, Rui Nunes
Ann Hepatol. 2024;29:101518
Acceso a texto completo
Hepatitis C virus NS5A and core protein induce fibrosis-related genes regulation on Huh7 cells through activation of LX2 cells
Tania G. Heredia-Torres, Veronica Alvarado-Martínez, Ana R. Rincón-Sánchez, Sonia A. Lozano-Sepúlveda, Kame A. Galán-Huerta, Daniel Arellanos-Soto, Ana M. Rivas-Estilla
Ann Hepatol. 2024;29:101517
Acceso a texto completo
The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease
Mingkai Li, Ying Lin, Hongsheng Yu, Weichun Lin, Jianning Chen, Yidong Yang, Bin Wu
Ann Hepatol. 2024;29:101516
Acceso a texto completo
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records
Ignat Drozdov, Benjamin Szubert, Ian A. Rowe, Timothy J. Kendall, Jonathan A. Fallowfield
Ann Hepatol. 2024;29:101528
Acceso a texto completo
Efficacy of blood plasma spectroscopy for early liver cancer diagnostics in obese patients
Petr Hříbek, Ondřej Vrtělka, Kateřina Králová, Johana Klasová, Markéta Fousková, Lucie Habartová, Kristýna Kubíčková, Tomáš Kupsa, ... Petr Urbánek
Ann Hepatol. 2024;29:101519
Acceso a texto completo
Development of a biodegradable prosthesis through tissue engineering, for the organ-replacement or substitution of the extrahepatic bile duct
Alan I. Valderrama-Treviño, Andrés E. Castell-Rodríguez, Rolando Hernández-Muñoz, Nadia A. Vázquez-Torres, Andrés Macari-Jorge, Baltazar Barrera-Mera, Alfredo Maciel-Cerda, Ricardo Vera-Graziano, ... Eduardo E. Montalvo-Javé
Ann Hepatol. 2024;29:101530
Acceso a texto completo
Letters to the editor
MAFLD or MASLD: Let the evidence decide again
Ziyan Pan, Mohammed Eslam
Ann Hepatol. 2024;29:101521
Acceso a texto completo
MAFLD vs. MASLD: Consensus is unlike evidence!
Enas Kamal, Alaa M Mostafa, Yasser Fouad
Ann Hepatol. 2024;29:101527
Acceso a texto completo
NAFLD-MASLD-MAFLD continuum: A swinging pendulum?
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Beatriz Barranco-Fragoso, Sandra M. Barbalho, Nahum Méndez-Sánchez
Ann Hepatol. 2024;29:101526
Acceso a texto completo
Hot topics in hepatology a multinational perspective
Alcohol-related liver disease: A global perspective
Graciela Elia Castro Narro, Luis Antonio Díaz, Eric Kauffman Ortega, María Fernanda Bautista Garín, Eira Cerda Reyes, Pindaro Sebastian Martinez Delfin, Juan Pablo Arab, Ramón Bataller
Ann Hepatol. 2024;29:101499
Acceso a texto completo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos